Lessons from REDUCE-IT
Video navigation menu
- Design and outcomes of the REDUCE-IT trial 00:46
- Total event analysis 04:19
- Safety with icosapent ethyl 06:21
- Subsequent analyses: REDUCE-IT EPA, DIABETES, and REVASC 09:23
This lecture by prof. Deepak Bhatt, MD was part of an accredited symposium "Novel opportunities tackling residual cardiovascular risk: The evolving role of triglycerides" held during the virtual ESC Congress 2020.
Prof. Deepak L. Bhatt, MD, MPH is Executive Director of Interventional Cardiovascular Programs and Professor at Harvard Medical School, Boston, MA, USA.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant from Amarin.